Cynosure, Inc., developer of the award-winning Smartlipo™ LaserBodySculpting(SM) procedure for minimally invasive removal of fat, and its largest shareholder, El.En. S.p.A, today announced a settlement of their patent infringement lawsuit against CoolTouch, Inc. Cynosure and El.En. alleged that CoolTouch's 1320 nm CoolLipo™ laser system infringed on El.En.'s U.S. Patent No. 6,206,873 (the 873 patent) licensed to Cynosure, which covers laser technology to remove subcutaneous fat. [More]

PriceDoc.com, a free, transparent healthcare pricing service and Web site, announced today that the U.S. Patent and Trademark Office issued PriceDoc patent #7,657,479 for its online system of healthcare service acquisition and negotiation, making PriceDoc.com the only online site where patients can "make an offer" for healthcare services with verified providers. [More]

NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 (Fludase®), and methods of treating or preventing viral infection by influenza and parainfluenza with such compositions. [More]

The U.S. District Court in the District of Delaware has ordered the dismissal of two patent infringement claims originally filed by Analog Devices, Inc. (ADI) against Knowles Electronics. The order was issued pursuant to the withdrawal of its claims by Analog Devices under a stipulation of dismissal signed by both parties. [More]

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the “Soutschek and Manoharan” patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery. [More]

Silence Therapeutics plc today announced that the United States Patent and Trademark Office (USPTO) has issued the company a notice of allowance on a patent application directed to methods of treatment using a high-value therapeutic target in the area of oncology. Known as PKN-3, the target is a protein kinase C-related molecule that is believed to play an important role in the growth of cancer cells, as well as metastasis formation. [More]

Consolidated Research of Richmond, Inc. (CRI) announces the awarding of United States Patent 7,654,948 - which is a novel, drug-free system for treating people suffering from the most common sleep complaint: Chronic Insomnia. [More]

Medicity—the leading provider of health information exchange (HIE) solutions that empower physicians, hospitals and communities to improve care coordination, collaboration and achieve meaningful use of health information technology—today announced the U.S. Patent and Trademark Office has awarded the company Patent No. 7,653,634 for its agent-grid technology for health information exchange. This patented technology, which is at the core of Medicity’s Novo Grid, has become the industry standard for seamless electronic health record (EHR) integration and community-wide health information exchange. [More]

Fate Therapeutics, Inc. received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application Number 10/997,146 entitled "Methods for Reprogramming Somatic Cells." Upon issuance, the patent will cover foundational induced pluripotent stem cell (iPSC) technology for identifying agents that enable the reprogramming of human somatic cells, including pluripotency genes, small molecules and biologics. [More]

Arrayit Corporation, a life sciences and healthcare technology leader, announced today that the Company has received patent protection in the State of Israel for its proprietary Variation Identification Platform™ (VIP™) DNA testing technology. The Israeli patent extends Arrayit's current patent portfolio, which includes VIP patents in the United States, Singapore, New Zealand, China, South Korea, and the European Union. [More]

Health Discovery Corporation announced today that the Company has received the final payment that was due under the agreement that settled the Company’s patent infringement lawsuit against Vermillion, formerly known as Ciphergen Biosystems, Inc. [More]

Rosetta Genomics today announced that the United States Patent and Trademark Office (USPTO) has issued three patents to the company covering the composition of matter of human microRNAs. [More]

Repligen Corporation announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office for a patent covering a recombinant form of Protein A which is identical in structure to the commercial form of Protein A from Staphylococcus aureus which is used in the production of many of the world's approved monoclonal antibodies. The patent, which will remain in force until 2028, covers a new Repligen proprietary product which is now available in commercial quantities. [More]

HealthSport, Inc., the preeminent formulator and developer of edible, multi-layer film strips that deliver drug and dietary supplement actives through buccal and sublingual absorption as well as oral ingestion, announced today that the Mexican Institute of Industrial Property has approved HealthSport's patent application relating to its bi-layer edible film strip technology. [More]

The American Civil Liberties Union has sued a genetics company that holds patents on breast- and ovarian-cancer-causing genes, saying their claims on the two genes hinders further research by other companies and scientists, the Associated Press/CBS News reports. [More]